Ozempic’s impact on kidney patients limited, Dialysis Provider DaVita says
DaVita Inc. downplayed the impact of GLP-1 drugs like Novo Nordisk A/S’s Ozempic after study results in kidney patients sent the dialysis-provider’s stock tumbling. The Denver-based...